Algorae Pharmaceuticals Ltd LVCLF
$0.01 $0.00 (18.13%) 1D
Last Updated: Jun 29, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
LVCLF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Algorae Pharmaceuticals Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Algorae Pharmaceuticals Ltd. Stock Analysis LVCLF
United States Health Care Nano Cap Algorae Pharmaceuticals Ltd. operates as an artificial intelligence enabled drug discovery and development company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The Company’s proprietary AI platform, Algorae Operating System (AlgoraeOS), is an AI platform that leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. Its other drug candidates include AI-116, AI-168, NTCELL. AI-116 is a combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer’s disease. AI-168 is a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient, which is conceptualized to be a potential treatment for cardiovascular disease, including hypertension. NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.
Algorae Pharmaceuticals Ltd (LVCLF) Chart
Financial Metrics & Statements of Algorae Pharmaceuticals Ltd (LVCLF)
FAQ's for Algorae Pharmaceuticals Ltd (LVCLF)
- As of August 2026, Algorae Pharmaceuticals Ltd LVCLF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Algorae Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Algorae Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Algorae Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Algorae Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Algorae Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Algorae Pharmaceuticals Ltd (LVCLF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
